|Over a week ago|
AMN Healthcare announces $250M share repurchase program » 08:3406/1506/15/22
The Board of Directors of…
The Board of Directors of AMN Healthcare Services, authorized an additional $250 million under the Company's repurchase program for the company's common stock. The Company has repurchased 6.76M shares of common stock at an average price of $77.44 per share excluding broker's fees, resulting in an aggregate purchase price of $523.5M, under the Share Repurchase Program since first authorized in 2016. Since the beginning of the second quarter, the Company has repurchased 1.88M shares at an average price of $92.65 for $173.8M. The total remaining dollar value of common stock that may be repurchased under the Increased Company Repurchase Program is approximately $326.3M.
|Over a month ago|
AMN Healthcare 'oversold on excessive fears,' says Jefferies » 08:0205/2405/24/22
Jefferies analyst Brian…
Jefferies analyst Brian Tanquilut raised the firm's price target on AMN Healthcare to $175 from $170 and keeps a Buy rating on the shares, which he believes have been "oversold on excessive fears around volume and rate normalization." Rates will likely continue to decline before bottoming later this year above pre-COVID levels, said Tanquilut, who contends that revenue compression is "more than baked into" current FY23 estimates and sees robust normalized growth post-2022.
AMN Healthcare acquires Connetics USA, terms not disclosed » 16:2005/1605/16/22
AMN Healthcare has…
AMN Healthcare has acquired Connetics USA, an international nurse and allied recruitment company that specializes in nursing and allied professional direct hire recruitment and placements. Connetics USA helps healthcare professional candidates through the immigration and licensure processes to their arrival in the United States. The company serves clients across the United States, including hospitals, dialysis facilities, long-term care facilities. "We are thrilled to have the Connetics USA team join the AMN Healthcare family and to expand our ability to serve clients across the country at such a critical time," said AMN Healthcare Chief Executive Officer Susan Salka. "The number one challenge facing healthcare organizations today is the growing shortage of healthcare professionals, which is expected to continue for several years. International staffing and recruitment solutions are an increasingly important response to this issue, and Connetics USA will help us bring more qualified and experienced international professionals to the United States."
AMN Healthcare sees Q2 revenue $1.34B-$1.38B, consensus $1.19B » 16:3605/0505/05/22
Sees Q2 gross margin…
Sees Q2 gross margin 31.5%-32%.
AMN Healthcare reports Q1 adjusted EPS $3.49, consensus $3.20 » 16:3505/0505/05/22
Reports Q1 revenue…
Reports Q1 revenue $1.55B, consensus $1.5B. "The AMN team continues to play a vital role in delivering a quality patient experience and supporting caregivers across the country. Strong healthcare demand in the first quarter was met with the tightest labor market we have ever seen. Our healthcare professionals and AMN team members worked relentlessly to help address the needs of the healthcare community, reaching our highest placement volume in Company history," said Susan R. Salka, Chief Executive Officer of AMN Healthcare. "We achieved record performance in our nursing, allied, locum tenens, interim leadership, search, language services, VMS, MSP and RPO businesses in the quarter."
|Over a quarter ago|
AMN Healthcare CEO Susan Salka to retire » 09:1103/1003/10/22
AMN Healthcare announced…
AMN Healthcare announced Susan Salka, its president and CEO, intends to retire by the end of the year upon the naming of her successor. AMN Healthcare chairman Douglas Wheat said Salka will stand for reelection to AMN's board and remain as CEO and a director until a successor is hired. The AMN Healthcare board of directors has a CEO succession process in place and is engaging a search firm to evaluate internal and external candidates.
AMN Healthcare price target raised to $140 from $125 at Benchmark » 10:1302/1802/18/22
Benchmark analyst Bill…
Benchmark analyst Bill Sutherland raised the firm's price target on AMN Healthcare to $140 from $125 and reiterates a Buy rating on the shares citing the company's "strong" guidance for Q1 and positive outlook for volumes for the remainder of 2022 and into 2023. AMN is seeing continued strong non-COVID related demand across its various service lines, Sutherland tells investors in a research note.
AMN Healthcare rises 13.6% » 09:4702/1802/18/22
AMN Healthcare is up…
AMN Healthcare is up 13.6%, or $12.71 to $106.00.
AMN Healthcare price target raised to $170 from $140 at Jefferies » 07:1902/1802/18/22
Jefferies analyst Brian…
Jefferies analyst Brian Tanquilut raised the firm's price target on AMN Healthcare to $170 from $140 and keeps a Buy rating on the shares. He is "bullish" on the shares following the company's earnings call, during which AMN management laid out a view on the company's normalized, post-COVID) earnings power and long-term growth trajectory that he says points to calendar 2023 EBITDA that is 25% above the current consensus, Tanquilut tells investors. AMN has been demonstrating its ability to recruit, fill orders, and drive significant volume and earnings growth with strong demand persisting even as COVID and nurse bill rates taper, the analyst added.
Fly Intel: After-Hours Movers » 18:2502/1702/17/22
APPN, LTHM, CGNX, SWAV, QDEL, AMN, ROKU, RDFN, SHAK, RUN, DLR, PPC, JAKK, DOMA, DBX
Check out this evening's…